Lockdown measures in response to COVID-19 in nine sub-Saharan African countries.
SARS
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
01
07
2020
revised:
09
09
2020
accepted:
11
09
2020
entrez:
8
10
2020
pubmed:
9
10
2020
medline:
27
10
2020
Statut:
ppublish
Résumé
Lockdown measures have been introduced worldwide to contain the transmission of COVID-19. However, the term 'lockdown' is not well-defined. Indeed, WHO's reference to 'so-called lockdown measures' indicates the absence of a clear and universally accepted definition of the term 'lockdown'. We propose a definition of 'lockdown' based on a two-by-two matrix that categorises different communicable disease measures based on whether they are compulsory or voluntary; and whether they are targeted at identifiable individuals or facilities, or whether they are applied indiscriminately to a general population or area. Using this definition, we describe the design, timing and implementation of lockdown measures in nine countries in sub-Saharan Africa: Ghana, Nigeria, South Africa, Sierra Leone, Sudan, Tanzania, Uganda, Zambia and Zimbabwe. While there were some commonalities in the implementation of lockdown across these countries, a more notable finding was the variation in the design, timing and implementation of lockdown measures. We also found that the number of reported cases is heavily dependent on the number of tests carried out, and that testing rates ranged from 2031 to 63 928 per million population up until 7 September 2020. The reported number of COVID-19 deaths per million population also varies (0.4 to 250 up until 7 September 2020), but is generally low when compared with countries in Europe and North America. While lockdown measures may have helped inhibit community transmission, the pattern and nature of the epidemic remains unclear. However, there are signs of lockdown harming health by affecting the functioning of the health system and causing social and economic disruption.
Identifiants
pubmed: 33028699
pii: bmjgh-2020-003319
doi: 10.1136/bmjgh-2020-003319
pmc: PMC7542624
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Microbiol Immunol Infect. 2020 Jun;53(3):467-472
pubmed: 32299783
Epidemiol Infect. 2020 Feb 26;148:e41
pubmed: 32100667
Lancet Infect Dis. 2020 May;20(5):546
pubmed: 32311326
Epidemiol Infect. 2020 Jun 09;148:e113
pubmed: 32513346
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Infect Dis. 2020 Jul;96:308-310
pubmed: 32437938
Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156